The historical rank and industry rank for TG Therapeutics's Days Inventory or its related term are showing as below:
TGTX'
s Days Inventory Range Over the Past 10 Years
Min: 844.83 Med: 1028.62 Max: 1028.62
Current: 844.83
During the past 13 years, TG Therapeutics's highest Days Inventory was 1028.62. The lowest was 844.83. And the median was 1028.62.
TGTX's Days Inventory is ranked worse than 88.75% of 649
companies
in the Biotechnology industry
Industry Median: 191.36
vs TGTX: 844.83
TG Therapeutics's Days Inventory
increased
from Dec. 2022 (0.00) to Dec. 2023 (426.25).
It might indicate that TG Therapeutics's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
TG Therapeutics's Inventory Turnover for the
three
months ended in Dec. 2023 was 0.21.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
TG Therapeutics's Inventory-to-Revenue for the
three
months ended in Dec. 2023 was 0.83.
TG Therapeutics Days Inventory Historical Data
The historical data trend for TG Therapeutics's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of TG Therapeutics's Days Inventory
For the Biotechnology subindustry, TG Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TG Therapeutics's Days Inventory Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, TG Therapeutics's Days Inventory distribution charts can be found below:
* The bar in red indicates where TG Therapeutics's Days Inventory falls into.
TG Therapeutics Days Inventory Calculation
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
TG Therapeutics's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TG Therapeutics (NAS:TGTX) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
TG Therapeutics's Inventory Turnover for the
three
months ended in Dec. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
TG Therapeutics's Inventory to Revenue for the
three
months ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
TG Therapeutics Days Inventory Related Terms
Thank you for viewing the detailed overview of TG Therapeutics's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
TG Therapeutics (TG Therapeutics) Business Description
TG Therapeutics Inc is a fully-integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS). and the company is developing TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb) for B-cell disorders which are under Phase 1 trial.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TGTX has been successfully added to your 